30 September 2016 - As Andrew B. Bindman began his tenure in May as director of the Agency for Healthcare Research and Quality, the agency had recently survived the threat of a congressional spending bill for fiscal year 2016 that proposed to eliminate its funding.

Although Agency endured, it was with a substantial budget cut, from $364 million to $334 million. As of press time, the agency was waiting to see if a proposed cut for fiscal year 2017 that would decrease its discretionary budget by 16% would be in the final bill.

Read JAMA news article